tirzepatide i danmark Price pressure on weight-loss drugs slows Eli Lilly's growth engine in the first quarter Tirzepatide cuts risk of diabetes

In earlier trials of tirzepatide, the medication was found to yield more average weight loss than other approved medicines, and in November, the US Food and Drug Administration approved it for people with obesity or those characterized as overweight with at least one weight-related health condition, such as high blood pressure or heart disease

We dose carefully, monitor your progress, and start with a free consultation built around your goals

Most people notice initial changes within a few weeks, with steady progress over the course of the program

Sergey Terushkin, MD, FACS is a fellowship-trained bariatric surgeon with experience in bariatric surgery, obesity medicine, medical weight loss, and long-term weight management